Cardiovascular monitoring and therapy for HIV-infected patients

Steven E. Lipshultz, Stacy D. Fisher, Wyman W. Lai, Tracie L. Miller

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Cardiovascular complications are important contributors to morbidity and mortality in HIV-infected patients. These complications can usually be detected at subclinical levels with monitoring, which can help guide targeted interventions. This article reviews available data on types and frequency of cardiovascular manifestations in HIV + patients and proposes monitoring strategies aimed at early subclinical detection. In particular, we recommend routine echocardiography for HIV + patients, even those with no evidence of cardiovascular disease. We also review preventive and therapeutic cardiovascular interventions. For procedures that have not been studied in HIV + patients, we extrapolate from evidence-based guidelines for the general population.

Original languageEnglish (US)
Pages (from-to)236-273
Number of pages38
JournalAnnals of the New York Academy of Sciences
StatePublished - 2001


  • AIDS
  • Atherosclerosis
  • Cardiovascular
  • Congestive heart failure
  • HIV

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Cardiovascular monitoring and therapy for HIV-infected patients'. Together they form a unique fingerprint.

Cite this